News
Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference
March 8, 2022
Roseville, MN – Tuesday, March 8, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that...
Read More
Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results
March 3, 2022
Reported achievement of milestones in the operationalization of its BioFactory™ production system, including the startup of its initial 200-liter pilot...
Read More
Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock
February 23, 2022
ROSEVILLE, Minn., February 23, 2022/PR Newswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt” or the “Company”), a plant-based synthetic biology company,...
Read More
Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants
February 17, 2022
ROSEVILLE, Minn., February 17, 2022 /PR Newswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt” or the “Company”), a plant-based synthetic biology...
Read More
Calyxt Appoints Gerry Nuovo as Senior Vice President of Business Development
February 7, 2022
Roseville, MN – Monday, February 7, 2022 – Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that...
Read More